Search

everythinglearnresearchcommunity

for

Search:↓

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

People with alopecia areata may be more likely to have a certain type of hearing loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Secukinumab for psoriasis may cause hair loss.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Insulin therapy helped a man with autoimmune issues regrow his hair.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

More research is needed on alopecia areata treatments and its psychological effects.

Stress can trigger or worsen alopecia areata.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.